| Erin Reynolds, CCC-SLP | |
|
913 Village Sq, Gretna, NE 68028-7853 | |
| (402) 932-0747 | |
| Not Available |
| Full Name | Erin Reynolds |
|---|---|
| Gender | Female |
| Speciality | Qualified Speech Language Pathologist |
| Experience | 7 Years |
| Location | 913 Village Sq, Gretna, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275040719 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2540 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Family Physical Therapy And Sports Center | 7214970177 | 31 |
News Archive
A range of evidence-based resources are now available from the Targeted Therapies Alliance to assist dermatologists and their patients in shared decision making in the treatment of plaque psoriasis.
What if you had to plan your outings based on how your stomach felt that day or where the nearest restroom is located? For many people with inflammatory bowel disease (IBD), their guts have an inordinate effect on their daily quality of life.
The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Nano Bridging Molecules SA, A Swiss med-tech company announced that it has received CE Mark (Conformité Européenne) approval to begin marketing its SurfLink® Dental product. With its bio mimicking properties, SurfLink® Dental has been shown to allow for natural and permanent integration of dental implants for the first time. Bone seems to perceive the SurfLink® Dental product as ‘body-like' and integrates the implant with a natural healing process, resulting in a quicker healing and a more stable integration, than without this product.
Revista Panamericana de Salud Pública/Pan American Journal of Public Health is seeking original research papers and other works dealing with primary health care.
› Verified 6 days ago
| Provider Name | Family Physical Therapy & Sports Center |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1356373658 PECOS PAC ID: 7214970177 Enrollment ID: O20050602000441 |
News Archive
A range of evidence-based resources are now available from the Targeted Therapies Alliance to assist dermatologists and their patients in shared decision making in the treatment of plaque psoriasis.
What if you had to plan your outings based on how your stomach felt that day or where the nearest restroom is located? For many people with inflammatory bowel disease (IBD), their guts have an inordinate effect on their daily quality of life.
The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Nano Bridging Molecules SA, A Swiss med-tech company announced that it has received CE Mark (Conformité Européenne) approval to begin marketing its SurfLink® Dental product. With its bio mimicking properties, SurfLink® Dental has been shown to allow for natural and permanent integration of dental implants for the first time. Bone seems to perceive the SurfLink® Dental product as ‘body-like' and integrates the implant with a natural healing process, resulting in a quicker healing and a more stable integration, than without this product.
Revista Panamericana de Salud Pública/Pan American Journal of Public Health is seeking original research papers and other works dealing with primary health care.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Reynolds, CCC-SLP 913 Village Sq, Gretna, NE 68028-7853 Ph: (402) 932-0747 | Erin Reynolds, CCC-SLP 913 Village Sq, Gretna, NE 68028-7853 Ph: (402) 932-0747 |
News Archive
A range of evidence-based resources are now available from the Targeted Therapies Alliance to assist dermatologists and their patients in shared decision making in the treatment of plaque psoriasis.
What if you had to plan your outings based on how your stomach felt that day or where the nearest restroom is located? For many people with inflammatory bowel disease (IBD), their guts have an inordinate effect on their daily quality of life.
The Multiple Myeloma Research Foundation (MMRF) today announced that its partner, Onyx Pharmaceuticals, Inc., received U.S. Food and Drug Administration (FDA) approval for Kyprolis (carfilzomib) for the treatment of patients with multiple myeloma who have received at least two prior therapies, including Velcade (bortezomib) for Injection and an immunomodulatory agent, such as Thalomid (thalidomide) or Revlimid (lenalidomide), and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Nano Bridging Molecules SA, A Swiss med-tech company announced that it has received CE Mark (Conformité Européenne) approval to begin marketing its SurfLink® Dental product. With its bio mimicking properties, SurfLink® Dental has been shown to allow for natural and permanent integration of dental implants for the first time. Bone seems to perceive the SurfLink® Dental product as ‘body-like' and integrates the implant with a natural healing process, resulting in a quicker healing and a more stable integration, than without this product.
Revista Panamericana de Salud Pública/Pan American Journal of Public Health is seeking original research papers and other works dealing with primary health care.
› Verified 6 days ago
Mrs. Nicole Jacobson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 South St, Gretna, NE 68028 Phone: 402-332-3048 | |
Cassandra Birdsall-scherer, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11316 S 170th St, Gretna, NE 68028 Phone: 402-499-1366 | |
Emily Harrington, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 913 Village Sq, Gretna, NE 68028 Phone: 402-932-0747 | |
Mrs. Harmony Rae Ames, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11705 S. 216th Street, Gretna, NE 68028 Phone: 402-332-3048 | |
Christine Kuhn, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 913 Village Sq, Gretna, NE 68028 Phone: 402-932-0747 | |
Mrs. Brenna Clarke, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11717 S 216th St, Gretna, NE 68028 Phone: 402-332-3265 | |
Mrs. Lindsay Craven, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11335 S 204th St, Gretna, NE 68028 Phone: 402-332-3936 |